CLARENCE, N.Y.--(BUSINESS WIRE)--Phase II Clinical Trial Featuring 22nd Century’s Very Low Nicotine Tobacco Accepted for Publication. Very Low Nicotine Cigarettes Reduce Frequency and Urges to Smoke, Help Smokers Quit.